Preventing early childhood myopia with special spectacle lenses and low-dose atropine
Official title: Project on Myopia Surveillance and Intervention Services for Preschool Children in Shanghai
Run by Shanghai Eye Disease Prevention and Treatment Center · NCT07176949 · Data updated 2026-11-12
This project will try spectacle lenses with highly aspherical lenslets and low-dose (0.01% and 0.05%) atropine eye drops to see if they slow myopia progression in children aged 3–6.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 3 Years to 6 Years |
| Sex | All |
| Enrollment | 508 (estimated) |
| Sponsor | Shanghai Eye Disease Prevention and Treatment Center Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | June 1, 2027 |
| Study ends | May 31, 2028 |
| Registry record updated | September 16, 2025 |
| Trial ID | NCT07176949 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 3–6 with early or pre-myopia (cycloplegic spherical equivalent up to +0.75 D), low astigmatism, good corrected visual acuity, and ability to wear spectacles and attend follow-up visits.
✕Probably not a fit
Children with strabismus, amblyopia, other ocular or systemic diseases affecting vision, or those who have recently used other myopia-control treatments are unlikely to benefit from enrollment.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Children aged 3–6 with early or pre-myopia will be enrolled and assigned to receive either spectacle lenses with highly aspherical lenslets or low-concentration atropine eye drops (0.01% or 0.05%). Vision and eye health, including cycloplegic refraction and other standard measures, will be monitored at regular visits to track refractive change and any side effects. Participants must be able to wear spectacles as required and attend follow-up visits at the study site. Outcomes will compare how much myopia progresses and the safety profile across the intervention groups.
Why it matters
Potential benefit: If successful, these interventions could slow progression to higher myopia in preschool children and reduce their lifetime risk of severe vision problems.
How similar studies have gone: Previous studies in older children have shown that defocus-type lenses and low-dose atropine can slow myopia, but evidence is limited for preschool-aged children.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 3-6 years, gender unrestricted; * Bilateral cycloplegic spherical equivalent (SE) ≤ +0.75 D, astigmatism ≤-2.5 D, anisometropia ≤2.5 D; * Best corrected visual acuity: ≥0.5 for ages 3-5, ≥0.7 for age 6; * Accept regular follow-up, written informed consent from guardians, verbal informed consent from children; * Possess normal thinking and language communication skills, and can actively cooperate to wear spectacles as required. Exclusion Criteria: * Existence of strabismus or amblyopia or other binocular vision abnormalities, accommodation dysfunction, cataract and history of eye surgery; * Any ocular or systemic disease that may affect vision and refractive development (e.g., Keratoconus, Marfan syndrome, retinopathy of prematurity, etc.); * Current or previous use of other treatments for myopia intervention, such as pharmacological (atropine) and optical (orthokeratology lenses or DIMS spectacle lenses) approaches, interrupt use for at least 4 weeks; * Allergy or contraindication to cycloplegic drugs; * Epilepsy or other mental disorders unable to expressing consent; * Other conditions deemed unsuitable for participation by the researcher.
Where it's running
-
Shanghai Eye Disease Prevention and Treatment Center
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Xiangui He, Prof
- Email: xianhezi@163.com
- Phone: +86 15000755422
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-assisted DIMS glasses to stop myopia in young children with pre-myopia
This trial tests whether AI-assisted DIMS-style glasses can help prevent myopia in children aged 3–6 who are at risk.
-
Virtual Far-sight Reading Device for Pre-myopia in Children
A device-guided reading program is tested to see if it can slow or prevent myopia in kids with pre-myopia and if it's safe with daily use for up to 6 months.
-
Evaluating a device for screening vision problems in young children
This study is testing a new device to see if it can effectively find vision problems in children aged 3 to 8, whether they wear glasses or not.
-
Optimizing light exposure to prevent and control myopia in children
This study tests if changing classroom lighting to mimic sunlight or using a smartphone app to guide light exposure can help prevent and control myopia in primary school children.
-
Hyperopic reserve screening for kindergartners in Beijing
A population-wide screening tests whether senior kindergarten children in Beijing have enough hyperopic reserve to help prevent future myopia.
-
Do dual-focus multifocal contact lenses improve hand-eye coordination and sports vision compared with your usual lenses
This study tests whether wearing dual-focus multifocal contact lenses improves hand-eye coordination and sports vision in adults who play baseball or softball and normally wear contact lenses.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.